PHARMACEUTICAL giant Bristol-Myers Squibb is investing £3.5m to expand its research and development (R&D) plant in Wirral.
The investment will see the company upgrade its existing facilities and create new laboratories at its Moreton site. It will secure the 100 jobs at the plant, which researches how to take newly-discovered medicines to market.
Bristol-Myers Squibb’s executive director of biopharmaceutics R&D, Dr Peter Timmins, said: “There are many reasons as to why Bristol-Myers Squibb has chosen to continue to significantly invest into the Wirral site – namely the exceptional quality and availability of skilled staff, the innovation and spirit that exists among the pharmaceutical community in the region, the world- class universities, the networking opportunities, the national and international connectivity, and the support received from The Mersey Partnership, Invest Wirral and the NWDA.”




